
November 1, 2025
UNC researchers unlock new way to help fight skin cancer
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.

November 1, 2025
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.

April 29, 2025
Pengda Liu, PhD, and colleagues have created a small molecule that targets and breaks down a protein linked to Ewing sarcoma, an aggressive cancer that mostly affects children and teens.

April 18, 2025
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.

October 22, 2024
Pengda Liu, PhD, and colleagues have identified an unexpected biological function of 2’3’-cGAMP, one that can facilitate cell migration and how cancer spreads.

May 21, 2024
UNC Lineberger’s Pengda Liu, PhD, and Benjamin Vincent, MD, were selected as Yang Family Biomedical Scholars in the eighth installment of this annual School of Medicine award.

November 1, 2023
Pengda Liu, PhD, is one of five UNC faculty members being honored with the Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement.

July 5, 2023
A team of UNC researchers have discovered how colon cancer “hijacks” enzyme motif mutations, a finding that may help identify new targets or directions for cancer treatments.

January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.

November 9, 2021
Pengda Liu, PhD, and Janelle Arthur, PhD, will present their research at the Jefferson-Pilot Fellowships in Academic Medicine and James W. Woods Junior Faculty Award Seminar during UNC Research Week.

June 1, 2021
Pengda Liu, PhD, Ian Davis, MD, PhD, and colleagues have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, as well as a compound that shows potential to block OTUD7A protein activity.